(Q50592804)

16 March 2018

MDMA

0 references

title

MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions. (English)

1 reference

16 March 2018

author

Gregor Domes

series ordinal

2

1 reference

16 March 2018

author name string

Cédric M Hysek

series ordinal

1

1 reference

16 March 2018

Matthias E Liechti

series ordinal

3

1 reference

16 March 2018

publication date

27 January 2012

1 reference

16 March 2018

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

16 March 2018

volume

222

1 reference

16 March 2018

issue

2

1 reference

16 March 2018

page(s)

293-302

1 reference

16 March 2018

https://scigraph.springernature.com/pub.10.1007/s00213-012-2645-9

exact match

0 references

cites work

The "Reading the Mind in the Eyes" Test Revised Version: A Study with Normal Adults, and Adults with Asperger Syndrome or High-functioning Autism

2 references

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

21 January 2018

12 December 2020

Effects of MDMA on sociability and neural response to social threat and social reward

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') using a drug discrimination paradigm in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Oxytocin attenuates amygdala responses to emotional faces regardless of valence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Oxytocin improves "mind-reading" in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Effects of intranasal oxytocin on emotional face processing in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Enhanced 'Reading the Mind in the Eyes' in borderline personality disorder compared to healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

The effect of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Oxytocin enhances the encoding of positive social memories in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Enhanced accuracy of mental state decoding in dysphoric college students

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Pharmacokinetics and pharmacodynamics of nasally delivered midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Oxytocin Enhances Amygdala-Dependent, Socially Reinforced Learning and Emotional Empathy in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Effects of the α₂-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Functional magnetic resonance imaging of reward prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Gender differences in the subjective effects of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Oxytocin improves specific recognition of positive facial expressions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Brain oxytocin: a key regulator of emotional and social behaviours in both females and males

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Effects of the noradrenergic agonist clonidine on temporal and spatial attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Acute norepinephrine reuptake inhibition decreases performance in normal and high ambient temperature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Cognitive and psychomotor function in hypoglycemia: response error patterns and retest reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

The Symptom Check-List-90-R (SCL-90-R): a German validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Oxytocin increases recognition of masked emotional faces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Social cognition under stress: differential effects of stress-induced cortisol elevations in healthy young men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy")

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Neural correlates of MDMA ("Ecstasy")-induced social interaction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2645-9

Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans

21 January 2018

1 reference

12 December 2020

Interleukin-1β Stimulates both Central and Peripheral Release of Vasopressin and Oxytocin in the Rat

1 reference

12 December 2020

The human amygdala and the emotional evaluation of sensory stimuli

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjects

1 reference

12 December 2020

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

12 December 2020

10.1007/S00213-012-2645-9

Identifiers

DOI

1 reference

16 March 2018

PubMed ID

22277989

1 reference

16 March 2018